Our clinical trial expertise. Your drug discovery pipeline.
At Aquila, we support you in successfully bringing your novel immunotherapy through clinical trials to market.
We offer a variety of clinical research services, including validated biomarker assays to evaluate the immune response to your drug candidate within the tumour and the TME.
As a specialist company that combines academic expertise with industrial standards, we use automated platforms to predict efficacy and safety of novel immuno-therapeutics.
In addition, we stratify patient response to your therapy with multiplex analysis of proteins and their spatial distribution within the tumour and/or TME. Our multiplex staining panels can be customised to meet a specific biomarker strategy during pre-clinical stages and beyond.
Please get in touch to learn more about how we can support your clinical trial.